Software AG reports second quarter and first half results
RESTON, Va.–(BUSINESS WIRE)–Following its preliminary results announcement on July 15, 2022, Software AG (Frankfurt MDAX®:…
Year: 2022
MBIA Inc. Investor Conference Call to Discuss Second Quarter 2022 Financial Results Scheduled for Thursday, August 4 at 8:00 A.M. Eastern Time
PURCHASE, N.Y.–(BUSINESS WIRE)–MBIA Inc. (NYSE:MBI) will host a webcast and conference call for investors on…
Unbabel Expands Leadership Team with Appointment of New CRO to Fuel Global Business Growth
Jennifer Bers will oversee the global revenue team and focus on new markets and revenue…
LeaseQuery’s Continued Focus on Simplifying Complex Accounting Results in Over 100 Percent Growth in First Half of 2022
LeaseQuery proves a winning combination for accounting and finance professionals ATLANTA–(BUSINESS WIRE)–#FASB—LeaseQuery, a leading provider…
Future Proof Announces Inaugural FintechX Demo Finalists
10 cutting edge fintechs have been awarded the opportunity to demo their innovations live to…
MIPI UniPro v2.0 Doubles Peak Data Rate and Delivers Greater Throughput and Reduced Latency for Flash Memory Storage Applications
Major update to UniPro specification delivers enhancements to support next-generation JEDEC UFS 4.0 standard PISCATAWAY,…
Linus Health Launches First iPad-Based Brain Health Platform for Early Detection of Alzheimer’s and Other Dementias in Primary Care
Platform Empowers Providers with Digital, AI-Based Solutions to Help Them Identify and Intervene on Brain…
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Agenus to Provide Corporate Update and Second Quarter 2022 Financial Report
Conference Call on Tuesday, August 9, 2022 at 8:30 a.m. ET LEXINGTON, Mass., July 27,…
PLx Pharma Inc. to Report Second Quarter 2022 Financial Results August 12, 2022, and Provide Business Update
SPARTA, N.J., July 27, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the…
Allogene Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Biotech startup Shiru appoints Dr. Ranjani Varadan as Chief Scientific Officer
Formerly Impossible Foods’ VP of R&D and VP of Strategic Ingredients, Varadan assumes new role…
TRACON to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 10, 2022
SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage…
Palisade Bio Announces First Patient Screened in Phase 3 Study Evaluating LB1148 for Postoperative Return of Bowel Function
CARLSBAD, Calif., July 27, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage…
Akoya to Participate at Two Upcoming Investor Conferences
MARLBOROUGH, Mass., July 27, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Medicenna Announces New Clinical Data Providing Preliminary Evidence of MDNA11’s Single Agent Anti-Cancer Activity in the Phase 1/2 ABILITY Study
— Tumor control was achieved in four of ten evaluable patients with advanced solid tumors…
INmune Bio, Inc. to Report Second Quarter 2022 Financial Results and Provide a Corporate Update on Wednesday, August 3
Management to host conference call and webcast at 4:30 pm ET on that day Boca…
Intercept to Announce Second Quarter 2022 Financial Results on August 3, 2022
MORRISTOWN, N.J., July 27, 2022 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company…
Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member
Appointment of Mr. Rowe, Eyenovia’s current Chief Operating Officer, maintains continuity while bringing significant ophthalmic…
Vaxart Provides New Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022, to Vote by August 3, 2022, at 11:59 p.m. ET
Key Proposal #2 Needs an Additional 0.9% of Outstanding Shares Votes to Pass Leading Independent…